Hepatitis B Vaccination Guidelines

Standard Schedules by Population

The Centers for Disease Control and Prevention recommends a standard hepatitis B vaccination schedule of 3 doses administered at 0, 1, and 6 months for most populations 1, 2
For infants born to HBsAg-positive mothers, the first dose should be given within 12 hours of birth plus HBIG, then at 1-2 months and 6 months 3
The final dose must not be administered before 24 weeks of age, regardless of when earlier doses were given 4, 5

Special Populations

Hemodialysis patients and immunocompromised adults should receive 40 μg doses of Recombivax HB at 0, 1, and 6 months 1, 6
Annual anti-HBs testing is recommended with booster doses when levels fall below 10 mIU/mL 4, 7
Pregnant women should use Engerix-B, Recombivax HB, or Twinrix only, and not use Heplisav-B or PreHevbrio due to insufficient safety data in pregnancy 6

Minimum Dosing Intervals

The minimum interval between doses 1 and 2 is 4 weeks, between doses 2 and 3 is 8 weeks, and between doses 1 and 3 is 16 weeks 4, 5, 7
Doses given ≤4 days before the minimum interval are considered valid 4, 5, 7

Interrupted Schedules

If the vaccination series is interrupted, do not restart the series—simply continue where you left off 4, 6, 5, 7
If interrupted after dose 1, give dose 2 as soon as possible, then dose 3 at least 8 weeks after dose 2 4

Alternative Accelerated Schedules

For rapid protection, Engerix-B can be given at 0, 1, 2, and 12 months, and Twinrix can be given at 0, 7, and 21-30 days, followed by a dose at 12 months 1, 3

Immunogenicity Considerations

After dose 1, 30-55% of individuals achieve protective antibody levels, after dose 2, 75% achieve protection, and after dose 3, >90% achieve protection with traditional vaccines 1
Heplisav-B achieves approximately 90% seroprotection compared to 70.5-90.2% with Engerix-B 1
Vaccine-induced immunity persists for >30 years 1

Common Pitfalls to Avoid

Never restart the series if interrupted, as this wastes doses and delays protection 4, 6, 5, 7
Do not give the third dose before 16 weeks from the first dose, even if 8 weeks have passed since the second dose 4, 5
Do not give the final infant dose before 24 weeks of age, as this may compromise long-term immunity 4, 5
Do not use standard adult doses in hemodialysis patients, as they require 40 μg doses 1, 6, 7
Do not use Heplisav-B or PreHevbrio in pregnant women, children, or hemodialysis patients 6

Hepatitis B Vaccine vs. Twinrix: Clinical Recommendation

Clinical Decision Framework

The American College of Physicians recommends using the hepatitis B vaccine alone for patients who only require hepatitis B protection and have no indication for hepatitis A vaccination 8, 9
The American College of Physicians suggests reserving Twinrix for patients who need protection against both hepatitis A and hepatitis B viruses 8, 9
International travelers to endemic regions requiring both vaccines should use Twinrix 8, 9
Men who have sex with men at risk for both infections should use Twinrix 9
Persons with chronic liver disease who need both vaccines should use Twinrix 9

Twinrix Dosing Schedules

The standard schedule for Twinrix is 3 doses at 0, 1, and 6 months 8, 9
An accelerated schedule for rapid protection can be used, with 4 doses administered on days 0, 7, and 21-30, followed by a booster at 12 months 8, 9

Key Advantages and Considerations

The American College of Physicians notes that Twinrix exposes patients to unnecessary hepatitis A antigen when not indicated 8, 9
The standard guidelines clearly distinguish between hepatitis A and hepatitis B vaccination indications 8, 9

Common Pitfalls to Avoid

The American College of Physicians advises against using Twinrix simply for hepatitis B vaccination when the patient has no indication for hepatitis A protection 8, 9

Hepatitis B Vaccine Schedules and Intervals

Standard Schedules by Population

The Centers for Disease Control and Prevention recommends a preferred schedule of 0, 1, and 6 months for adolescents and adults, with alternative schedules of 0, 2, and 4 months or 0, 1, and 4 months producing similar seroprotection rates 10, 11, 12
Schedules with 2-month intervals between doses produce good antibody response and may be appropriate when ensuring follow-up is difficult, with the highest antibody titers achieved when the last two doses are spaced at least 4 months apart 10, 11

Interrupted Schedules and Immunogenicity

Increasing the interval between doses has little effect on final immunogenicity, but longer intervals between the last 2 doses result in higher final antibody levels 12
The standard 0, 1, 6-month schedule produces a protective antibody response in more than 90% of adults under 40 years, but response rates decline with age 12

Hepatitis B Vaccination Guidelines

Special Populations and Vaccination Schedules

The Centers for Disease Control and Prevention (CDC) recommends post-vaccination testing for infants born to HBsAg-positive mothers at 9-15 months of age for HBsAg and anti-HBs, as stated by the Morbidity and Mortality Weekly Report 13
Delaying the birth dose beyond 12 hours in infants born to HBsAg-positive mothers significantly increases infection risk, according to the Morbidity and Mortality Weekly Report 13

Hepatitis B Vaccination Guidelines for Healthcare Workers (CDC)

Recommended Vaccination Schedule

The CDC recommends that all unvaccinated healthcare workers with anticipated exposure to blood or body fluids complete a three‑dose hepatitis B vaccine series administered at 0, 1, and 6 months. 14

Mandatory Post‑Vaccination Serologic Testing

The CDC requires high‑risk healthcare workers to undergo anti‑HBs serologic testing 1–2 months after the final vaccine dose to confirm immunity. 14
Testing must use an assay capable of detecting a protective anti‑HBs concentration of ≥10 mIU/mL. 14
Serologic testing determines immune status, guides post‑exposure prophylaxis decisions, and identifies non‑responders who need revaccination. 14
Healthcare workers with anti‑HBs ≥10 mIU/mL are considered immune, and this result must be documented in their occupational health record. 14
Immunocompetent individuals with documented adequate response have long‑term protection and do not require periodic repeat testing. 14

Management of Non‑Responders (Anti‑HBs < 10 mIU/mL)

The CDC advises that healthcare workers who remain non‑responsive after the primary series receive a second complete three‑dose series, followed by repeat anti‑HBs testing 1–2 months after the third dose of the second series. 14
Administering a full second series is considered more practical than testing after each additional dose. 14
If anti‑HBs remains <10 mIU/mL after a total of six doses, testing for HBsAg and anti‑HBc should be performed to assess infection status. 14
Confirmed non‑responders after six doses should be counseled about their continued susceptibility and the need for hepatitis B immune globulin (HBIG) plus a vaccine dose for any known or likely exposure to HBsAg‑positive blood. 14

Timing Considerations for Trainees

The CDC emphasizes that the vaccination series should be completed before healthcare trainees have any contact with blood, as the training period carries a higher risk of exposure. 14
Vaccination should be offered in schools of medicine, dentistry, nursing, laboratory technology, and other allied health programs prior to clinical exposure. 14

CDC Guidelines on Accelerated Hepatitis B and Hepatitis A/B Vaccination Schedules

Approved Vaccination Schedules

The CDC has not approved any accelerated schedule for monovalent hepatitis B vaccines (e.g., Engerix‑B or Recombivax HB); however, the combined hepatitis A/B vaccine Twinrix is approved for an accelerated regimen of doses on day 0, day 7, and day 21‑30, followed by a booster at 12 months. 15, 16, 17, 18
For monovalent hepatitis B vaccines, the standard schedule recommended by the CDC is three doses at 0, 1, and 6 months for most populations. 15, 16, 17, 18
Alternative hepatitis B schedules (0, 1, 4 months or 0, 2, 4 months) achieve seroprotection rates comparable to the standard schedule, but they are not classified as “accelerated” because they still require four months to complete. 15, 16, 17, 18
Twinrix (combined hepatitis A/B) standard schedule per CDC guidance is three doses at 0, 1, and 6 months. 15, 16, 17, 18
Twinrix accelerated schedule per CDC guidance consists of doses on day 0, day 7, and day 21‑30, with a fourth booster dose at 12 months. 15, 16, 17, 18

Clinical Recommendations for Rapid Protection

When rapid protection against hepatitis B alone is required, clinicians should use the standard monovalent hepatitis B series (0, 1, 6 months); no CDC‑approved accelerated alternative exists. 15, 16, 17, 18
When both hepatitis A and B protection are needed (e.g., for last‑minute travelers or high‑risk exposures), the CDC recommends the Twinrix accelerated schedule (0, 7, 21‑30 days) plus the 12‑month booster. 15, 16, 17, 18

Common Pitfalls to Avoid

Do not place monovalent hepatitis B vaccines on an “accelerated” schedule; the alternative 0‑1‑4 month or 0‑2‑4 month regimens still require four months to complete and are not CDC‑endorsed as accelerated. 15, 16, 17, 18
Do not omit the 12‑month booster dose when using the Twinrix accelerated schedule, as the booster is required by CDC guidance to achieve long‑term immunity. (The need for the booster is part of the CDC‑approved schedule.)
Do not use Twinrix solely for hepatitis B immunization when hepatitis A protection is not indicated, because this would expose the patient to unnecessary antigen. (CDC recommends Twinrix only when protection against both viruses is clinically indicated.)

Hepatitis B Vaccine Dosing and Schedule Guidelines (CDC)

1. Standard Dosing for Healthy Adults

The CDC recommends that healthy adults ≥ 20 years receive 10 µg of Recombivax HB or 20 µg of Engerix‑B intramuscularly at 0, 1, and 6 months, achieving >95 % seroprotection. 19, 20
The deltoid muscle is the preferred injection site for adults; administration in the buttock markedly reduces immunogenicity. 21

2. Dosing for Infants and Children

For infants born to HBsAg‑negative mothers, the CDC advises 5 µg of Recombivax HB or 10 µg of Engerix‑B at 0, 1–2, and 6 months of age. 22
The first dose should be given at birth or within the first two months of life. 21, 20
The anterolateral thigh is the preferred injection site for neonates and infants. 21
For infants born to HBsAg‑positive mothers, a 10 µg dose of Engerix‑B plus HBIG must be administered within 12 hours of birth, followed by doses at 1–2 months and 6 months. 22
Children and adolescents 11–19 years should receive 5 µg of Recombivax HB or 10 µg of Engerix‑B at 0, 1, and 6 months. 19
An alternative 2‑dose schedule (10 µg adult‑formulation Recombivax HB at 0 and 4–6 months) is approved for adolescents 11–15 years. 19, 22
Pediatric doses are 50–75 % lower than adult doses. 21, 20

3. Dosing for Hemodialysis and Chronic Kidney Disease Patients

For adult hemodialysis patients ≥ 20 years, the CDC recommends a high‑dose regimen: 40 µg Recombivax HB at 0, 1, and 6 months or 40 µg Engerix‑B (two 20 µg injections at one site) at 0, 1, 2, and 6 months. 19, 22
Standard adult doses (10–20 µg) are insufficient in dialysis patients, yielding only ~50 % seroprotection versus 67 % with the 40 µg regimen. 19

4. Minimum Dosing Intervals

The CDC defines the minimum intervals as: 4 weeks between dose 1 and dose 2, 8 weeks between dose 2 and dose 3, and 16 weeks between dose 1 and dose 3. 22
Doses given ≤4 days before the minimum interval are still considered valid. 22
Extending the interval between the last two doses to 4–12 months results in higher final antibody titers. 21, 20

5. Management of Interrupted Schedules

If the series is interrupted, do not restart; continue from the point of interruption. 20, 22
After a missed dose 2, administer it as soon as possible, then give dose 3 at least 8 weeks after dose 2 and at least 16 weeks after dose 1. 22
If only dose 3 is delayed, it may be given at the next convenient opportunity. 20

6. Accelerated Twinrix Schedule (Hepatitis A + B)

For rapid dual protection in adults ≥ 18 years, the CDC recommends Twinrix at 0, 7, and 21–30 days, followed by a booster at 12 months. 22

7. Post‑Vaccination Antibody Testing (Hemodialysis & Immunocompromised)

The CDC advises measuring anti‑HBs titers 1–2 months after completing the series in hemodialysis and other immunocompromised patients to confirm protective levels (≥10 mIU/mL). 22

8. Common Pitfalls (CDC Alerts)

Never use standard adult doses (10–20 µg) in hemodialysis patients; they require the 40 µg high‑dose regimen. 19
Never administer the third dose before 16 weeks from the first dose, even if 8 weeks have elapsed since the second dose. 22
Never inject hepatitis B vaccine into the buttock of adults, as this substantially lowers immunogenicity. 21

CDC Guidance on Managing Inadvertent Pediatric Hepatitis B Doses in Adults

Immediate Corrective Action

Series Continuation (No Restart)

Scheduling of Remaining Adult Doses

Documentation Requirements

Critical Pitfalls to Avoid

CDC Recommendations for Hepatitis B Vaccination in Adults

Standard Adult Schedule

The CDC recommends that hepatitis‑naïve adults receive Engerix‑B (20 µg/1.0 mL) intramuscularly in the deltoid at months 0, 1, and 6 to complete the standard three‑dose series. 25
Each adult dose must contain the full 1.0 mL volume (20 µg of hepatitis B surface antigen). 25

Minimum Interval Requirements

Minimum interval between dose 1 and dose 2 is 4 weeks (28 days). 25
Minimum interval between dose 2 and dose 3 is 8 weeks. 25
Minimum interval between dose 1 and dose 3 is 16 weeks. 25
A grace period of up to 4 days before the minimum interval is acceptable; doses given within this window are considered valid. 25

Immunogenicity and Duration of Protection

In healthy adults younger than 40 years, the standard 3‑dose series yields seroprotection in >90 % of recipients. 25
Protective immunity induced by the series persists for more than 30 years in immunocompetent individuals. 25

Combined Hepatitis A & B Vaccination

For simultaneous hepatitis A and B protection, the CDC advises using Twinrix (20 µg/1.0 mL) on the standard 0, 1, 6‑month schedule or the accelerated 0, 7, 21–30‑day plus 12‑month schedule. 25

Special Populations – Adjusted Dosing

Adults on hemodialysis require a double dose (40 µg total; two 1.0 mL injections at the same site) administered on a 4‑dose schedule at months 0, 1, 2, and 6. 25
Standard 20 µg adult doses are insufficient for hemodialysis patients and must be replaced with the 40 µg high‑dose regimen. 25

Common Prescribing Pitfalls (CDC Alerts)

Administering the third dose before 16 weeks from the first dose is prohibited, even if the 8‑week interval after the second dose has been met. 25
Using the pediatric formulation (10 µg/0.5 mL) in adults ≥20 years is an inadequate dose and must be avoided. 25
Injecting the vaccine into the buttock rather than the deltoid markedly reduces immunogenicity and should not be done. 25